elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q33373434-5072ECAF-0A10-45A9-ABBB-F0FEA9E466D8
Q33373434-5072ECAF-0A10-45A9-ABBB-F0FEA9E466D8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33373434-5072ECAF-0A10-45A9-ABBB-F0FEA9E466D8
Phase II study of cisplatin plus epirubicin salvage chemotherapy in refractory germ cell tumors.
P31
Q33373434-5072ECAF-0A10-45A9-ABBB-F0FEA9E466D8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33373434-5072ECAF-0A10-45A9-ABBB-F0FEA9E466D8
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
85e2ba54c3cfe151c7c36ce215a356fb7a6e1b3c
P31
scholarly article